Gonadotrophin-releasing hormone receptors in GtoPdb v.2021.3 by Heitman, Laura H. et al.
IUPHAR/BPS	Guide	to	Pharmacology	CITE
https://doi.org/10.2218/gtopdb/F31/2021.3
Gonadotrophin-releasing	hormone	receptors	in	GtoPdb
v.2021.3
Laura	H.	Heitman1,	Adriaan	P.	IJzerman2,	Craig	A.	McArdle3	and	Adam	J	Pawson4
1.	 Universiteit	Leiden,	The	Netherlands
2.	 Leiden	University,	The	Netherlands
3.	 University	of	Bristol,	UK
4.	 The	University	of	Edinburgh,	UK
Abstract
GnRH1	and	GnRH2	receptors	(provisonal	nomenclature	[39],	also	called	Type	I	and	Type	II	GnRH
receptor,	respectively	[85])	have	been	cloned	from	numerous	species,	most	of	which	express	two	or
three	types	of	GnRH	receptor	[85,	84,	114].	GnRH	I	(p-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2)
is	a	hypothalamic	decapeptide	also	known	as	luteinizing	hormone-releasing	hormone,	gonadoliberin,
luliberin,	gonadorelin	or	simply	as	GnRH.	It	is	a	member	of	a	family	of	similar	peptides	found	in	many
species	[85,	84,	114]	including	GnRH	II	(pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2	(which	is	also
known	as	chicken	GnRH-II).	Receptors	for	three	forms	of	GnRH	exist	in	some	species	but	only	GnRH
I	and	GnRH	II	and	their	cognate	receptors	have	been	found	in	mammals	[85,	84,	114].	GnRH1
receptors	are	expressed	by	pituitary	gonadotrophs,	where	they	mediate	the	effects	of	GnRH	on
gonadotropin	hormone	synthesis	and	secretion	that	underpin	central	control	of	mammalian
reproduction.	GnRH	analogues	are	used	in	assisted	reproduction	and	to	treat	steroid	hormone-
dependent	conditions	[58].	Notably,	agonists	cause	desensitization	of	GnRH-stimulated	gonadotropin
secretion	and	the	consequent	reduction	in	circulating	sex	steroids	is	exploited	to	treat	hormone-
dependent	cancers	of	the	breast,	ovary	and	prostate	[58].	GnRH1	receptors	are	selectively	activated
by	GnRH	I	and	all	lack	the	COOH-terminal	tails	found	in	other	GPCRs.	GnRH2	receptors	do	have
COOH-terminal	tails	and	(where	tested)	are	selective	for	GnRH	II	over	GnRH	I.	GnRH2	receptors	are
expressed	by	some	primates	but	not	by	humans	[88].	Phylogenetic	classifications	divide	GnRH
receptors	into	three	[85]	or	five	groups	[129]	and	highlight	examples	of	gene	loss	through	evolution,
with	humans	retaining	only	one	ancient	gene.	The	structure	of	the	GnRH1	receptor	in	complex	with
elagolix	has	been	elucidated	[132].
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